{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:34:18Z","timestamp":1793255658068,"version":"4.5.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Australian National Health and Medical Research Council Investigator","award":["GNT1197958"],"award-info":[{"award-number":["GNT1197958"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,29]]},"abstract":"<jats:title>Vignette<\/jats:title>\n                  <jats:p>A premenopausal woman was reviewed for painful vertebral fractures in the context of prednisolone exposure for her newly diagnosed systemic lupus erythematosus (SLE). Known clinical risk factors for bone loss included exposure to depot medroxyprogesterone acetate (MPA) for 12\u00a0yr, cigarette smoking, a family history of osteoporosis and ongoing inflammatory arthritis. Initial investigations also identified vitamin D deficiency and low bone mass for age and sex. She was treated with vitamin D, and her contraception was changed to a levonorgestrel intrauterine device. In the context of further vertebral fractures confirmed with both MRI and bone scan and having had additional secondary causes of low bone mass excluded, she commenced targeted osteoporosis treatment. We discuss the complexities of managing bone fragility in young adults and the impact of depot MPA, inflammatory disease (SLE), and glucocorticoid-induced osteoporosis (GIO) on younger adults. In this woman, antiresorptive therapy with zoledronic acid was recommended; we also explore the existing evidence-base for antiresorptive and anabolic therapies in younger adults, with a particular focus on GIO.<\/jats:p>","DOI":"10.1093\/jbmr\/zjag088","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:40:54Z","timestamp":1779277254000},"page":"1180-1185","source":"Crossref","is-referenced-by-count":0,"title":["Vertebral fractures in a young woman: the impact of hypogonadism, glucocorticoids, and chronic disease"],"prefix":"10.1093","volume":"41","author":[{"given":"Madhuni","family":"Herath","sequence":"first","affiliation":[{"name":"Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research , Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Medicine, School of Clinical Sciences, Monash University , Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Endocrinology, Monash Health , Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Endocrinology and Diabetes, Western Health , Melbourne, VIC 3011 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8846-6168","authenticated-orcid":false,"given":"Hanh H","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Clinical Sciences, Monash University , Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Endocrinology, Monash Health , Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Endocrinology and Diabetes, Western Health , Melbourne, VIC 3011 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-4376","authenticated-orcid":false,"given":"Frances","family":"Milat","sequence":"additional","affiliation":[{"name":"Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research , Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Medicine, School of Clinical Sciences, Monash University , Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Endocrinology, Monash Health , Melbourne, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2921-3742","authenticated-orcid":false,"given":"Peter R","family":"Ebeling","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Clinical Sciences, Monash University , Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Endocrinology, Monash Health , Melbourne, VIC 3168 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"10","key":"2026102901482988900_ref1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/jbmr\/zjae119","article-title":"Goal-directed osteoporosis treatment: ASBMR\/BHOF task force position statement 2024","volume":"39","author":"Cosman","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026102901482988900_ref2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1359\/jbmr.2003.18.7.1254","article-title":"Association between vertebral fracture and increased mortality in osteoporotic patients*","volume":"18","author":"Jalava","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026102901482988900_ref3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2021","journal-title":"Endocr Rev"},{"issue":"1","key":"2026102901482988900_ref4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00198-016-3714-4","article-title":"The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK","volume":"28","author":"Kyvernitakis","year":"2017","journal-title":"Osteoporos Int"},{"issue":"6","key":"2026102901482988900_ref5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.contraception.2008.07.014","article-title":"The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women","volume":"78","author":"Vestergaard","year":"2008","journal-title":"Contraception"},{"issue":"5","key":"2026102901482988900_ref6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00223-017-0322-z","article-title":"Bone disease in connective tissue disease\/systemic lupus erythematosus","volume":"102","author":"Bultink","year":"2018","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2026102901482988900_ref7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026102901482988900_ref8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11657-018-0424-x","article-title":"Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study","volume":"13","author":"Amiche","year":"2018","journal-title":"Arch Osteoporos"},{"issue":"11","key":"2026102901482988900_ref9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S2213-8587(25)00251-7","article-title":"Glucocorticoid-induced osteoporosis: novel concepts and clinical implications","volume":"13","author":"Hofbauer","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2026102901482988900_ref10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/cen.14637","article-title":"Challenges in the diagnosis and management of glucocorticoid-induced osteoporosis in younger and older adults","volume":"96","author":"Herath","year":"2022","journal-title":"Clin Endocrinol"},{"issue":"8","key":"2026102901482988900_ref11","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1210\/clinem\/dgaa306","article-title":"Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF","volume":"105","author":"Pepe","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026102901482988900_ref12","doi-asserted-by":"publisher","first-page":"e3540","DOI":"10.1210\/clinem\/dgaa489","article-title":"Effect of teriparatide on bone remodeling and density in premenopausal idiopathic osteoporosis: a phase II trial","volume":"105","author":"Cohen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"2026102901482988900_ref13","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"2026102901482988900_ref14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jbmr.4739","article-title":"Teriparatide followed by denosumab in premenopausal idiopathic osteoporosis: bone microstructure and strength by HR-pQCT","volume":"38","author":"Agarwal","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2026102901482988900_ref15","doi-asserted-by":"crossref","first-page":"e791","DOI":"10.1210\/clinem\/dgae240","article-title":"Bisphosphonates maintain BMD after sequential teriparatide and denosumab in premenopausal women with idiopathic osteoporosis","volume":"110","author":"Kamanda-Kosseh","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026102901482988900_ref16","doi-asserted-by":"publisher","first-page":"e2778","DOI":"10.1210\/clinem\/dgae810","article-title":"Comparison of efficacy of romosozumab with denosumab and risedronate in patients newly initiating glucocorticoid therapy","volume":"110","author":"Kawazoe","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026102901482988900_ref17","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omae089","article-title":"Multiple thoracolumbar compression fractures induced by glucocorticoid-induced osteoporosis and cachexia in a young adult female patient with systemic lupus erythematosus: a case report with a 5-year follow-up","volume":"2024","author":"Fujimoto","year":"2024","journal-title":"Oxf Med Case Rep"},{"issue":"4","key":"2026102901482988900_ref18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.afos.2023.10.001","article-title":"Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa","volume":"9","author":"Fujimoto","year":"2023","journal-title":"Osteoporos Sarcopenia"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag088\/68374467\/zjag088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/11\/1180\/68374467\/zjag088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/11\/1180\/68374467\/zjag088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:48:33Z","timestamp":1793252913000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/41\/11\/1180\/8691502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":18,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,5,23]]},"published-print":{"date-parts":[[2026,10,29]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjag088","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,5,23]]}}}